may cause withdrawal symptoms.Side effects:Nausea, somnolence, sweating, tremor, insomnia, asthenia, dry mouth, dizziness, bijwerkingen stoppen met paroxetine sexual dysfunction, constipation, diarrhea, decreased appetite.Interactions:See Contraindications. MAOIs, Phenobarbital, theophylline, 5HT1 agonists bijwerkingen stoppen met paroxetine sumatriptan).

1% of paroxetine treated bijwerkingen stoppen met paroxetine experienced manic reactions. When bipolar patients were considered as a sub-group the incidence of mania was 2%. As with other Selective Serotonin bijwerkingen stoppen met paroxetine Inhibitors (SSRIs), bijwerkingen stoppen met paroxetine bijwerkingen stoppen met paroxetine be used bijwerkingen stoppen met paroxetine caution in patients with a history bijwerkingen stoppen met paroxetine mania.Occupational Hazards:Although paroxetine did not cause sedation or interfere with psychomotor performance in placebo-controlled studies in normal subjects, patients bijwerkingen stoppen met paroxetine be advised to avoid driving a car or operating hazardous machinery until they are reasonably certain that paroxetine does not affect them adversely.Cardiac Conditions:Paroxetine does not bijwerkingen stoppen met paroxetine produce clinically significant changes in blood pressure, heart rate or ECG. Paroxetine bijwerkingen stoppen met paroxetine not been evaluated or used to any bijwerkingen stoppen met paroxetine bijwerkingen stoppen met paroxetine bijwerkingen stoppen met paroxetine bijwerkingen stoppen met paroxetine with a recent history of myocardial infarction or unstable heart bijwerkingen stoppen met paroxetine Hence, the usual precautions bijwerkingen stoppen met paroxetine bijwerkingen stoppen met paroxetine observed bijwerkingen stoppen met paroxetine such patients.Electroconvulsive Therapy (ECT):The efficacy and bijwerkingen stoppen met paroxetine of the.

have not been established.Pregnancy and Lactation:Although animal studies have not shown bijwerkingen stoppen met paroxetine teratogenic or selective.